Erratum: Identification of novel fusion inhibitors of influenza a virus by chemical genetics (J Virol (2016) 90:5 (2690–2701) DOI: 10.1128/JVI.02326-15);Identification of novel fusion inhibitors of influenza A virus by chemical genetics

Journal of Virology

Volumn 90, Issue 5, 2016, Pages 2690-2701

  Lai, Kin Kui ^a   Cheung, Nam Nam ^a   Yang, Fang ^a   Dai, Jun ^a   Liu, Li ^a   Chen, Zhiwei ^a   Sze, Kong Hung ^a,b   Chen, Honglin ^a,b   Yuen, Kwok Yung ^a,b   Kao, Richard Yi Tsun ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ 2; UNCLASSIFIED DRUG; VIRUS FUSION INHIBITOR; VIRUS HEMAGGLUTININ; HEMAGGLUTININ HA-2 FUSOGENIC PEPTIDE, INFLUENZA VIRUS;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; INFLUENZA A VIRUS; MOLECULAR DOCKING; NONHUMAN; PH; PHENOTYPE; PRIORITY JOURNAL; REVERSE GENETICS; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS IDENTIFICATION; VIRUS RESISTANCE; ANIMAL; ANTIVIRAL RESISTANCE; CELL LINE; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MUTATION;

ANIMALS; CELL LINE; DRUG RESISTANCE, VIRAL; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS; MOLECULAR DOCKING SIMULATION; MUTATION; REVERSE GENETICS; VIRAL FUSION PROTEIN INHIBITORS;

EID: 84961159800     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00665-21     Document Type: Erratum

References (40)

1. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, Li Y, Yao X, Zhang Y, Wu H, Zheng S, Diao H, Xia S, Chan KH, Tsoi HW, Teng JL, Song W, Wang P, Lau SY, Zheng M, Chan JF, To KK, Chen H, Li L, Yuen KY. 2013. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381:1916-1925. http://dx.doi.org/10.1016/S0140-6736(13)60903-4.
2. Taubenberger JK, Kash JC. 2010. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7:440-451. http://dx.doi.org/10.1016/j.chom.2010.05.009.
3. Xiong X, Martin SR, Haire LF, Wharton SA, Daniels RS, Bennett MS, McCauley JW, Collins PJ, Walker PA, Skehel JJ, Gamblin SJ. 25 July 2013, posting date. Receptor binding by an H7N9 influenza virus from humans. Nature http://dx.doi.org/10.1038/nature12372.
4. To KK, Chan JF, Chen H, Li L, Yuen KY. 2013. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis 13:809-821. http://dx.doi.org/10.1016/S1473-3099(13)70167-1.
5. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, Cheung PT, To WK, Ho ET, Sung R, Cheng AF. 1998. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467-471. http://dx.doi.org/10.1016/S0140-6736(98)01182-9.
6. Wang J, Wu Y, Ma C, Fiorin G, Pinto LH, Lamb RA, Klein ML, Degrado WF. 2013. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Proc Natl Acad Sci U S A 110:1315-1320. http://dx.doi.org/10.1073/pnas.1216526110.
7. Das K, Aramini JM, Ma LC, Krug RM, Arnold E. 2010. Structures of influenza A proteins and insights into antiviral drug targets. Nat Struct Mol Biol 17:530-538. http://dx.doi.org/10.1038/nsmb.1779.
8. Palmer R. 2011. Drugs: Lines of defence. Nature 480:S9-S10. http://dx.doi.org/10.1038/480S9a.
9. Pleschka S. 2013. Overview of influenza viruses. Curr Top Microbiol Immunol 370:1-20.
10. Samji T. 2009. Influenza A: understanding the viral life cycle. Yale J Biol Med 82:153-159.
11. Gamblin SJ, Skehel JJ. 2010. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 285:28403-28409. http://dx.doi.org/10.1074/jbc.R110.129809.
12. Yang J, Li M, Shen X, Liu S. 2013. Influenza A virus entry inhibitors targeting the hemagglutinin. Viruses 5:352-373. http://dx.doi.org/10.3390/v5010352.
13. Xu R, Wilson IA. 2011. Structural characterization of an early fusion intermediate of influenza virus hemagglutinin. J Virol 85:5172-5182. http://dx.doi.org/10.1128/JVI.02430-10.
14. Luo M. 2012. Influenza virus entry. Adv Exp Med Biol 726:201-221. http://dx.doi.org/10.1007/978-1-4614-0980-9_9.
15. Plotch SJ, O'Hara B, Morin J, Palant O, LaRocque J, Bloom JD, Lang SA, Jr, DiGrandi MJ, Bradley M, Nilakantan R, Gluzman Y. 1999. Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin. J Virol 73:140-151.
16. Minagawa K, Kouzuki S, Kamigauchi T. 2002. Stachyflin and acetylstachyflin, novel anti-influenza A virus substances, produced by Stachybotrys sp. RF-7260. II. Synthesis and preliminary structure-activity relationships of stachyflin derivatives. J Antibiot (Tokyo) 55:165-171.
17. Luo G, Colonno R, Krystal M. 1996. Characterization of a hemagglutinin-specific inhibitor of influenza A virus. Virology 226:66-76. http://dx.doi.org/10.1006/viro.1996.0628.
18. Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, Colacino JM, Muesing MA. 1998. Inhibition of influenza virus hemagglutininmediated membrane fusion by a compound related to podocarpic acid. Virology 248:264-274. http://dx.doi.org/10.1006/viro.1998.9273.
19. Zhu X, Yu W, McBride R, Li Y, Chen LM, Donis RO, Tong S, Paulson JC, Wilson IA. 2013. Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities. Proc Natl Acad Sci U S A 110:1458-1463. http://dx.doi.org/10.1073/pnas.1218509110.
20. Bodian DL, Yamasaki RB, Buswell RL, Stearns JF, White JM, Kuntz ID. 1993. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry 32:2967-2978. http://dx.doi.org/10.1021/bi00063a007.
21. Russell RJ, Kerry PS, Stevens DJ, Steinhauer DA, Martin SR, Gamblin SJ, Skehel JJ. 2008. Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc Natl Acad Sci U S A 105:17736-17741. http://dx.doi.org/10.1073/pnas.0807142105.
22. Hoffman LR, Kuntz ID, White JM. 1997. Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity. J Virol 71:8808-8820.
23. Boriskin YS, Leneva IA, Pécheur EI, Polyak SJ. 2008. Arbidol: a broadspectrum antiviral compound that blocks viral fusion. Curr Med Chem 15:997-1005. http://dx.doi.org/10.2174/092986708784049658.
24. Kao RY, Yang D, Lau LS, Tsui WH, Hu L, Dai J, Chan MP, Chan CM, Wang P, Zheng BJ, Sun J, Huang JD, Madar J, Chen G, Chen H, Guan Y, Yuen KY. 2010. Identification of influenza A nucleoprotein as an antiviral target. Nat Biotechnol 28:600-605. http://dx.doi.org/10.1038/nbt.1638.
25. Zheng BJ, Chan KW, Lin YP, Zhao GY, Chan C, Zhang HJ, Chen HL, Wong SS, Lau SK, Woo PC, Chan KH, Jin DY, Yuen KY. 2008. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci U S A 105:8091-8096. http://dx.doi.org/10.1073/pnas.0711942105.
26. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97:6108-6113. http://dx.doi.org/10.1073/pnas.100133697.
27. Ao Z, Patel A, Tran K, He X, Fowke K, Coombs K, Kobasa D, Kobinger G, Yao X. 2008. Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules. Antiviral Res 79:12-18. http://dx.doi.org/10.1016/j.antiviral.2008.02.001.
28. Nefkens I, Garcia JM, Ling CS, Lagarde N, Nicholls J, Tang DJ, Peiris M, Buchy P, Altmeyer R. 2007. Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J Clin Virol 39:27-33. http://dx.doi.org/10.1016/j.jcv.2007.02.005.
29. Min JY, Krug RM. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 103:7100-7105. http://dx.doi.org/10.1073/pnas.0602184103.
30. Vanderlinden E, Goktas F, Cesur Z, Froeyen M, Reed ML, Russell CJ, Cesur N, Naesens L. 2010. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin. J Virol 84:4277-4288. http://dx.doi.org/10.1128/JVI.02325-09.
31. Yoshimoto J, Kakui M, Iwasaki H, Fujiwara T, Sugimoto H, Hattori N. 1999. Identification of a novel HA conformational change inhibitor of human influenza virus. Arch Virol 144:865-878. http://dx.doi.org/10.1007/s007050050552.
32. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, Wilson IA. 2004. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303:1866-1870. http://dx.doi.org/10.1126/science.1093373.
33. Trott O, Olson AJ. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455-461.
34. Wallace AC, Laskowski RA, Thornton JM. 1995. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8:127-134. http://dx.doi.org/10.1093/protein/8.2.127.
35. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25:1605-1612. http://dx.doi.org/10.1002/jcc.20084.
36. Skehel JJ, Bayley PM, Brown EB, Martin SR, Waterfield MD, White JM, Wilson IA, Wiley DC. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A 79:968-972. http://dx.doi.org/10.1073/pnas.79.4.968.
37. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. 2000. The Protein Data Bank. Nucleic Acids Res 28:235-242. http://dx.doi.org/10.1093/nar/28.1.235.
38. Noda T. 2011. Native morphology of influenza virions. Front Microbiol 2:269.
39. Thoennes S, Li ZN, Lee BJ, Langley WA, Skehel JJ, Russell RJ, Steinhauer DA. 2008. Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion. Virology 370:403-414. http://dx.doi.org/10.1016/j.virol.2007.08.035.
40. Basu A, Antanasijevic A, Wang M, Li B, Mills DM, Ames JA, Nash PJ, Williams JD, Peet NP, Moir DT, Prichard MN, Keith KA, Barnard DL, Caffrey M, Rong L, Bowlin TL. 2014. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza A virus fusion. J Virol 88:1447-1460. http://dx.doi.org/10.1128/JVI.01225-13.